Disease Management Update

Swavely D, Merkle LN, Bub S, et al. A diabetes disease management model in the primary care setting. J Clin Outcomes Manag 2002 Dec; 9: 683–8. Lynd LD, Guh DP, Paré PD, et al. Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest 2002 Dec; 122: 1973–81. Thoonen BPA, Schermer TRJ, van den Boom G, et al. Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial. Thorax 2003 Jan; 58: 30–6. Müller-Lissner SA, Pirk O. Irritable bowel syndrome in Germany: a cost of illness study. Eur J Gastroenterol Hepatol 2002 Dec; 14: 1325–9. Petrou S, Cooper P, Murray L, et al. Economic costs of post-natal depression in a highrisk British cohort. Br J Psychiatry 2002 Dec; 181: 505–12. Morgan JD, Wright DJ, Chrystyn H. Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepines. Pharm World Sci 2002 Dec 24: 231–5. Stone R. DMAA leader predicts coming trends for DM industry. Dis Man News 2003 Jan; 8: 2, 25. Bigger co-payments lead to falls in compliance, new US survey finds. Pharmaceut J 2003 Jan 18; 270: 69. Levit K, Smith C, Cowan C, et al. Trends in U.S. health care spending, 2001: the rise in health care’s share of GDP is more a result of a slowing economy than of rising health spending. Health Aff 2003 Jan-Feb; 22: 154–64. Lopert R, Henry D. The Pharmaceutical Benefits Scheme: economic evaluation works … but is not a panacea. Aust Prescriber 2002; 26(2): 126–7. Goodfellow AF, Wai AO, Frighetto L, et al. Quality-of-life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother 2002 Dec; 36: 1851–5. McCandless RR. Attributing inpatient Medicare costs to diabetes among the Texas elderly. Diabetes Care 2002 Nov; 25: 1958–63. Crystal-Peters J, Neslusan CA, Smith MW, et al. Health care costs of allergic rhinitisassociated conditions vary with allergy season. Ann Allergy Asthma Immunol 2002 Nov; 89: 457–62. Wändell PE, Gåfvels C. Drug prescription in men and women with type-2 diabetes in Stockholm in 1995 and 2001: change over time. Eur J Clin Pharmacol 2002 Nov; 58: 547–53. Jencks SF, Huff ED, Cuerdon T. Change in the quality of care delivered to Medicare beneficiaries, 1998–1999 to 2000–2001. JAMA 2003 Jan 15; 289: 305–12. Hsia DC. Medicare quality improvement: bad apples or bad systems? JAMA 2003 Jan 15; 289: 354–6. Schlackman N. Determining the appropriate role of pharmaceuticals in a changing health care system. P & T 2002 Dec 2002; Suppl.: 4–6. Lippe G, Rose B, Norman G, et al. Health plans’ interest in infant care DM on the rise. Dis Manag News 2002 Dec 25; 8: 1, 4–5. Fleishman M. Issues in psychopharmacosocioeconomics. Psychiatr Serv 2002 Dec; 53: 1532–4.